INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Embecta Corp. of Class Action Lawsuit and Upcoming Deadlines – EMBC

Pomerantz LLP announces that a class action lawsuit has been filed against Embecta Corp. (“Embecta” or the “Company”) (NASDAQ: EMBC). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased. The class action concerns whether Embecta and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. You have until August 17, 2026, to ask the Court to appoint you as Lead Plaintiff for the class if you purchased or otherwise acquired Embecta securities during the Class Period. A copy of the Complaint can be obtained at www.pomerantzlaw.com. On May 5, 2026, Embecta announced its second quarter 2026 financial results, disclosing that Embecta missed its guidance for the second quarter and lowered its guidance for the 2026 fiscal year. Among other results, Embecta disclosed that its revenue declined over 14%, much higher than the guidance of flat to a decline of 2%, and that Embecta was lowering estimates on U.S. performance, largely in part due to weakness in its pen needle sales. On this news, the price of Embecta stock decline nearly 58%, damaging investors.